BIOFORCE NANOSCIENCES HOLDINGS, INC.
Income Statement
| Line Item | Aug 2025 | Jun 2025 | May 2025 | Apr 2025 | Mar 2025 | Dec 2024 | Nov 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $17.0K | — | — | $27.7K | — | — | $16.3K |
| Operating Income | — | $-122.8K | — | — | $-133.5K | — | — | $-122.0K |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $-122.8K | — | — | $-133.5K | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $-122.8K | — | — | $-935.5K | — | — | $-122.0K |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | $0.00 | — | — | $-0.03 | — | — | $0.00 |
| EPS (Diluted) | — | $0.00 | — | — | $-0.03 | — | — | $0.00 |
| Shares Outstanding (Basic) | 33.5M | 33.5M | 33.5M | 33.5M | 32.2M | 29.3M | 29.3M | 29.3M |
| Shares Outstanding (Diluted) | 33.5M | 33.5M | 33.5M | 33.5M | 32.2M | 29.3M | 29.3M | 29.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |
All I want to know is where I'm going to die so I'll never go there.